Papers
1
Total Citations
45
H-Index
1
About
Ke‐Fei Xu is a pioneering researcher in bionic microrobotics and advanced drug delivery systems, with a focus on overcoming biological barriers for cancer therapy. Their most notable contribution is the development of a red blood cell‐derived bionic microrobot, published in 2023, which hierarchically adapts to five critical stages in systemic drug delivery—from circulation to tumor penetration and subcellular targeting. This work, already garnering 45 citations, addresses a fundamental challenge in oncology: the complexity of biological barriers that limit chemotherapeutic efficacy. By mimicking the natural properties of red blood cells, Xu’s design achieves enhanced tumor-targeting efficiency, offering a transformative approach to anticancer treatment. Their research integrates principles of biomimicry, materials science, and nanomedicine, positioning them at the forefront of intelligent drug delivery systems. Xu’s work not only advances fundamental understanding of bionic design but also holds promise for clinical translation, making them a key figure in the next generation of therapeutic microrobots.
Research Focus
Key Achievements
Top Papers
- 1